ENTRY       D11443                      Drug
NAME        Garetosmab (USAN);
            Garetosmab (genetical recombination) (JAN)
FORMULA     C6472H10004N1712O2024S42
EXACT_MASS  145436.0785
MOL_WEIGHT  145525.6682
SEQUENCE    (Heavy chain)
            QVQLQESGPG LVKPSETLSL TCTVSGGSFS SHFWSWIRQP PGKGLEWIGY ILYTGGTSFN
            PSLKSRVSMS VGTSKNQFSL KLSSVTAADT AVYYCARARS GITFTGIIVP GSFDIWGQGT
            MVTVSSASTK GPSVFPLAPC SRSTSESTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP
            AVLQSSGLYS LSSVVTVPSS SLGTKTYTCN VDHKPSNTKV DKRVESKYGP PCPPCPAPEF
            LGGPSVFLFP PKPKDTLMIS RTPEVTCVVV DVSQEDPEVQ FNWYVDGVEV HNAKTKPREE
            QFNSTYRVVS VLTVLHQDWL NGKEYKCKVS NKGLPSSIEK TISKAKGQPR EPQVYTLPPS
            QEEMTKNQVS LTCLVKGFYP SDIAVEWESN GQPENNYKTT PPVLDSDGSF FLYSRLTVDK
            SRWQEGNVFS CSVMHEALHN HYTQKSLSLS LGK
            (Light chain)
            EIVLTQSPGT LSLSPGERAT LSCRASQSVS SSYLAWYQQK PGQAPRLLIY GASSRATGIP
            DRFSGSGSGT DFTLTISRLE PEDFAVYYCQ QYGSSPWTFG QGTKVEIKRT VAAPSVFIFP
            PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS QESVTEQDSK DSTYSLSSTL
            TLSKADYEKH KVYACEVTHQ GLSSPVTKSF NRGEC
            (Disulfide bridge: H22-H95, H140-L215, H153-H209, H232-H'232, H235-H'235, H267-H327, H373-H431, H'22-H'95, H'140-L'215, H'153-H'209, H'267-H'327, H'373-H'431, L23-L89, L135-L195, L'23-L'89, L'135-L'195)
  TYPE      Peptide
EFFICACY    Activin modulator
  TYPE      Monoclonal antibody
COMMENT     Prevention and treatment of heterotopic ossification in patients with fibrodysplasia ossificans progressive (FOP)
DBLINKS     CAS: 2097125-54-5
            PubChem: 384585420
///
